An NVDA board member filed sales totalling roughly $410 million in early September, making it one of the largest recent insider disposals in US markets.
Mark A. Stevens, an independent director at NVIDIA Corporation, filed the transactions on 2 September. The trades took place between 31 August and 2 September. Stevens sold batches of 300,000 shares at a time across several filings, at prices implying around $220 per share. NVIDIA's General Counsel, Timothy Teter, also filed sales of roughly $6.5 million on the same date.
NVIDIA's short interest sits at just 1.3% of free float, so the selling is not a squeeze risk. The stock carries a market cap of around $5.5 trillion.
The sales come as Taiwan's total export orders hit a record $103 billion in August 2026, up 71% year on year, according to ORTEX Alt Data. NVIDIA is a key beneficiary of that semiconductor demand surge, which makes large director sales worth watching.
Separately, Fosun Pharma Industrial, a promoter shareholder in Indian-listed Gland Pharma, filed sales of around $296 million on 8 September. Nippon Paper Industries also disclosed a $397 million disposal of its stake in Japan's LINTEC Corporation around the same date.
Stevens' NVIDIA sales are discretionary open-market transactions with no 10b5-1 plan flag in the filing data, giving them a stronger signal than pre-arranged plan sales.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
